
Mark Therapeutics Private Limited
Develops alternative therapeutics for drug-resistant bacteria in humans, poultry, and fisheries.
Develops alternative therapeutics for drug-resistant bacteria in humans, poultry, and fisheries.
Mark Therapeutics Private Limited (MTPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 22 August 2019 (Five years and nine months 9 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Consumer Electronics & Durables Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Aruna Kalle, Srinivas Kota, Kumbha Ramani, and Two other members serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U73100TG2019PTC134971
134971
Private Limited Indian Non-Government Company
22 Aug 2019
30 Nov 2021
31 Mar 2021
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Aruna Kalle ![]() | Director | 22-Aug-2019 | Current |
Srinivas Kota ![]() | Director | 22-Aug-2019 | Current |
Kumbha Ramani ![]() | Director | 22-Aug-2019 | Current |
Kota Prasad ![]() | Director | 22-Aug-2019 | Current |
Vemuri Chari ![]() | Director | 22-Aug-2019 | Current |
Mark Therapeutics Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Mark Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Aruna Kalle is a mutual person
Aruna Kalle is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Mark Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mark Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mark Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mark Therapeutics Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Mark Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad.
Aruna Sree Marasanapalli Kalle was appointed as a Director was appointed as a Director on 22 Aug 2019 & has been associated with this company since 5 years 9 months .
Srinivas Naga Laxmi Narasimha Kota was appointed as a Director was appointed as a Director on 22 Aug 2019 & has been associated with this company since 5 years 9 months .
Kumbha Roja Ramani was appointed as a Director was appointed as a Director on 22 Aug 2019 & has been associated with this company since 5 years 9 months .
Kota Krishna Prasad was appointed as a Director was appointed as a Director on 22 Aug 2019 & has been associated with this company since 5 years 9 months .
Mark Therapeutics Private Limited was incorporated on 22 Aug 2019.
The authorized share capital of Mark Therapeutics Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 5 directors are associated with Mark Therapeutics Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Mark Therapeutics Private Limited is 12-10-587/2/B Road No 4 Medibhavi Seethafalmandi, India, Secunderabad, Telangana, 500061.
The corporate identification number (CIN) of Mark Therapeutics Private Limited is U73100TG2019PTC134971 and the company number is 134971 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Mark Therapeutics Private Limited was filed with the ROC on 31 Mar 2021.
Search company & director profiles for free and gain access to critical business data.